Rimon
Save as PDF RSS Feed Subscribe

Rimon Law Welcomes Life Sciences and Intellectual Property Lawyer David Devernoe as Partner in its San Diego Office

News David Devernoe David Devernoe · January 11, 2019

San Diego- Continuing to expand the firm’s Intellectual Property team, Rimon Law has added David Devernoe, who has served as both an in-house and outside counsel for a host of IP focused Life Science and Medical Technology companies, as Partner in its San Diego Office.

Mr. Devernoe joins Rimon from Troutman Sanders, where he also was Partner. Mr. Devernoe had previously worked as senior patent counsel for Hologic (NASDQ: HOLX), a medical technology company.

Mr. Devernoe focuses on providing a business-level understanding of his client’s patent needs. His extensive experience includes advising companies from start-ups to multi-national organizations. He has significant experience in all areas of health and medicine, including medical diagnostics, digital health, additive manufacture and 3-D printing, medical devices and AR/VR software and devices, near-eye displays and imaging/optical technologies, smart garments, compression garments, health and beauty, food prep and catering, athletic equipment, nutraceuticals, machine learning software and devices, nucleic acid sequencing, bioinformatics and data translation, antibody products and targets, immunology-focused technologies, CART-T targets and therapy, consumer devices and services, and information technology.

He has also served as a guest lecturer at the University of San Diego School of Law on the topic of Intellectual Property in Corporate Transactions.

At Rimon, Mr. Devernoe brings his IP experience to a booming IP team, which grew by 12 attorneys this year alone, including fellow life science patent prosecution Partners Peng Chen in San Diego and Justin Zahrt in Silicon Valley. The IP team focuses on helping clients not only protect their IP assets but also on how best to develop and maximize the value of those assets to advance business interests. With Rimon’s decentralized business model, Mr. Devernoe will be able to customize his practice to the needs of each of his clients with the highest efficiency.

“We continue to see an expansion in the importance of the Life Science field. David is one of the leading IP practitioners in the life science arena. His deep well of experience, handling patent issues for medical technology and other IP and healthcare companies, will be invaluable to our practice. David’s business-focused mindset has been widely praised by his clients. He has an intuitive understanding of what the client needs to succeed in business and how to help make that happen. We are very pleased to welcome David to Rimon,” said Michael Moradzadeh, CEO of Rimon.

“My clients have looked to me for both my knowledge of IP and for running a lean and purpose-driven practice, one which seeks to smooth the path to success for clients. The Rimon platform truly understands these goals. I believe my clients will be served well by Rimon’s flexible and adaptive platform that helps attorneys focus on both the legal and business needs of clients,” said Mr. Devernoe.

Mr. Devernoe earned a J.D. from Case Western University where he was Publisher and Associate Editor of the Case Western Reserve Law Review. While at the Law Review, he authored an article on genetically modified foods that was awarded Note of the Year by the American Agricultural Law Association. He received his B.S. from Union College. 

Rimon has 20 offices across three continents. The firm is widely known as being at the vanguard of legal innovation. The firm has been repeatedly recognized by the Financial Times as one of North America's most innovative law firms. The firm’s Managing Partners were both named ‘Legal Rebels’ by the American Bar Association’s ABA Journal and have spoken on innovations in the practice of law at Harvard and Stanford Law Schools. Rimon and its lawyers have also received numerous awards for excellence, including from Best Lawyers and Chambers.

.